Cancer Commons

@cancercommons

A nonprofit giving patients the information they need. Learn more:

Vrijeme pridruživanja: srpanj 2012.

Tweetovi

Blokirali ste korisnika/cu @cancercommons

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cancercommons

  1. proslijedio/la je Tweet
    prije 16 sati

    "For every patient who is diagnosed w/ stage IV (mCRC), complete molecular profiling of their tumor is highly recommended. It is important for pts to know their microsatellite status, RAS (KRAS & NRAS) & BRAF mutations, & HER2 amplification status at a minimum."

    Poništi
  2. prije 21 sat
    Poništi
  3. 4. velj

    Our expert network is ready to help you answer your questions about cancer treatment, clinical trials, and more. Get one-on-one support today:

    Poništi
  4. 31. sij

    After an advanced cancer diagnosis, what questions should you ask your doctor? Our experts weigh in:

    Poništi
  5. 30. sij
    Poništi
  6. 29. sij

    We’re thrilled to have shared promising initial findings from our real-world data registry on a novel treatment for earlier this month at . Thank you to collaborators at xCures & . More from :

    Poništi
  7. 28. sij

    Thank you to everyone who attended and participated in our dedicated Patient Track at last week! We believe in keeping patients' needs at the center of conversations about oncology, and we're thrilled to have heard so many valuable perspectives.

    Poništi
  8. 27. sij

    Are you or a loved one dealing with a new cancer diagnosis? Cancer Commons can help. Sign up for our free services at

    Poništi
  9. 25. sij

    As we embrace 2020, we reflect on the previous year w/ deep gratitude for our generous donors. Their philanthropic support made 2019 a year of great progress for us & the patients we serve. To everyone who gave what they could, thank you. We couldn’t have done it without you.

    Poništi
  10. proslijedio/la je Tweet

    Today, ’s joins & a panel of industry leaders at to explore how functional precision medicine impacts patients, particularly ovarian, & how new tech & partnerships will shape clinical oncology's future.

    Poništi
  11. proslijedio/la je Tweet
    24. sij

    We are all patients. Some r patients. cares. focuses a patient track 1/24/2020

    Poništi
  12. proslijedio/la je Tweet
    24. sij

    Precision oncology works well for SOME cancer patients is explaining the best ways Hope; not Hype with real can succeed

    Poništi
  13. 24. sij

    Today we’re thrilled to be co-hosting a dedicated Patient Track at , w/ great speakers lined up to share their perspectives on putting patients first. More info: Hope to see you there!

    Poništi
  14. 23. sij

    "In a perfect world, I see Cancer Commons’ services as an integral part of a patient’s treatment plan." Read Marilou's story:

    Poništi
  15. proslijedio/la je Tweet
    20. sij
    Poništi
  16. proslijedio/la je Tweet

    In 1 1/2 weeks! 's Shweta Singh Maniar will chair "AI/ML-Driven Clinical Trial Design and Patient Selection" Speakers > > M. Ali > A. Schneider >

    Poništi
  17. 20. sij

    Our expert network is ready to help you answer your questions about cancer treatment, clinical trials, and more. Get support today:

    Poništi
  18. 17. sij
    Poništi
  19. 16. sij

    “Though the study includes a small number of patients...this regimen could potentially be an option for this group of patients who don’t have many more options.” Excited to share initial results from our registry on a novel tx:

    Poništi
  20. 14. sij

    Coming up soon! We’ve co-organized a dedicated Patient Track at , w/ great speakers lined up to share their perspectives on putting patients first. Patients can register at a steep discount. More info: Hope to see you there.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·